☆ 4.5 Article

PARP inhibitors and metastatic castration-resistant prostate cancer: uture directions and pitfalls

TRANSLATIONAL ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Understanding and overcoming resistance to PARP inhibitors in cancer therapy

Mariana Paes Dias et al.

Summary: PARP inhibitors have shown success in treating certain cancer patients, but most will develop resistance to these inhibitors, prompting the need for novel treatment strategies. Current research efforts are focused on finding ways to overcome resistance mechanisms.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Olaparib for Metastatic Castration-Resistant Prostate Cancer

J. de Bono et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Oncology

The emerging role of PARP inhibitors in prostate cancer

Marco Stellato et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2020)

添加到收藏夹

Article Oncology

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration

Wassim Abida et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Review Cell Biology

PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells

Sylvie M. Noordermeer et al.

TRENDS IN CELL BIOLOGY (2019)

添加到收藏夹

Article Oncology

Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial

Noel Clarke et al.

LANCET ONCOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Integrative Clinical Genomics of Advanced Prostate Cancer

Dan Robinson et al.

CELL (2015)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.